Call Our Free Legal Helpline Anytime

or call

31 August 2015

400 New Xarelto Lawsuits Added to MDL Case in August 2015

In recent weeks, hundreds of Xarelto lawsuits have been added to the multi-district litigation (MDL) case that’s currently proceeding through the federal courts.

It has been reported that approximately 400 new Xarelto blood thinner lawsuits have been consolidated into MDL 2592, which is currently moving forward under Judge Eldon Fallon, of the U.S. District Court of the Eastern District of Louisiana.

In a multi-district litigation case, similar lawsuits which involve the same basic facts are condensed into a single case for certain aspects of the process, such as discovery and evidence sharing. Notably, each case is still tried separately, despite the fact that certain pre-trial proceedings are consolidated.

The number of Xarelto lawsuits has been climbing steadily in recent months. The Xarelto MDL now includes over 1230 individual cases. This reflects a massive growth, as there were only 500 cases in June 2015 and just over 800 cases in mid-July 2015.

Basic Facts in the Xarelto Lawsuits and MDL

The defendants in the Xarelto lawsuit MDL include Johnson & Johnson subsidiary, Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals, the makers of the blood thinner drug marketed under the name Xarelto (rivaroxaban.)

The plaintiffs are a diverse group of individuals, including individuals who suffered uncontrolled bleeding after taking Xarelto and family member of individuals who died from bleeding while on the blood thinner drug.

The average age of patients who’ve suffered fatal uncontrolled bleeding incidents is 82, according to one study. Approximately 75% of the non-fatal uncontrolled bleeding cases involved individuals age 75 and older.

Collectively, the plaintiffs have made several allegations:

  • They allege that Xarelto marketing materials did not clearly convey the risk of uncontrolled bleeding;
  • They allege that the anti-coagulant drug’s marketing materials over-stated the benefits (such as a reduced need for blood monitoring on Xarelto blood thinners) and the drug failed to carry sufficient warning labels about the dangers.
  • They claim that they were never informed of the fact that Xarelto has no antidote.
  • They argue that it was negligent to release a blood thinner drug without an antidote or emergency treatment.

A “new generation” blood thinner drug, Xarelto was marketed as a safer, more convenient alternative to Warfarin/Coumadin, which requires frequent blood testing to ensure the patient maintains therapeutic levels of the anti-coagulant drug.

But unlike Coumadin, which can be reversed with infusions of Vitamin K, Xarelto has no antidote. Even the drug’s competitor, Pradaxa, can be reversed using emergency dialysis. Even this method won’t help a patient who’s taken Xarelto.

Critics not only call for frequent blood monitoring in patients taking Xarelto; they’re also calling for more stringent patient warnings. The FDA issued a warning to the drug’s manufacturers in 2013 due to the fact that marketing materials “minimized” Xarelto’s risks.

While there have been some claims that Xarelto is no more dangerous than Warfarin, multiple studies have revealed very different findings.

One study, published in April 2015, revealed that Xarelto brought a two-fold increase in the risk of gastrointestinal bleeding compared to Warfarin. Xarelto has also been linked to many other forms of internal bleeding, including:

  • Rectal bleeding
  • Kidney bleeding
  • Brain hemorrhaging
  • Eye hemorrhaging
  • Uncontrolled bleeding incidents.

Xarelto Bellwether trials are scheduled to get underway in about one year’s time in August 2016. The Bellwether trials are designed to determine the viability of the many similar cases that have been consolidated into a multi-district litigation case. Based on the outcome of the Bellwether trials, the plaintiffs can decide whether they wish to proceed with a trial, accept a settlement or drop the case entirely. In some cases where the juries hand down massive awards to the plaintiff, the defendants may opt to offer settlements rather than taking the cases to trial in an attempt to limit loss.

Do You Have a Possible Xarelto Lawsuit?

Did you or a family member suffer Xarelto side effects involving internal bleeding and hemorrhaging? If so, you may have a legal right to financial compensation, helping you recover costs such as medical bills, funeral costs and lost wages.

It’s important to take action immediately because each state has a statute of limitations – a law that limits how long you have to file a case. So don’t miss out on your opportunity to get the legal justice and financial compensation that you deserve.

Contact The Meldofsky Firm LLC today to schedule a free and totally confidential Xarelto case consultation.

Our experienced legal team is standing by, ready to help you get the compensation you deserve. Call the Meldofsky Firm today at (877) 274-8672.

You may be eligible for financial compensation.

Name is required.
Email is required.
Phone is required.
Medical condition required.